Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

This marks the latest recall-related issue for HeartMate in recent years. Last June, the FDA deemed another recall as serious ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse platform.

Kardium today announced one-year clinical trial results for its Globe PF pulsed field ablation (PFA) system for treating AFib ...

HeartBeam announced that it entered into a strategic collaboration with AccurKardia to enhance cardiac monitoring ...

SonoMotion announced that it received a $2.2 million NIH grant and successfully completed enrollment in a pivotal clinical ...

Olympus announced today that it appointed Bob White, former Medtronic EVP, as its new CEO, effective June 1, 2025.

The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium ...

Medtronic (NYSE: MDT) announced a strategic agreement to distribute Dragonfly Endoscopy's Dragonfly pancreaticobiliary system ...

ClearPoint Neuro (Nasdaq:CLPT) announced that it kicked off the full-market launch of its latest navigation software.